Lineage Cell Therapeutics
Earnings Surprise
Analysts estimated LCTX earnings of $-0.03 per share this quarter (Q3). LCTX's actual earnings were $-0.13 per share.
LCTX EPS surprise of -396.18%Analysts estimated LCTX earnings of $-0.03 per share this quarter (Q2). LCTX's actual earnings were $-0.07 per share.
LCTX EPS surprise of -152.71%Analysts estimated LCTX earnings of $-0.03 per share this quarter (Q1). LCTX's actual earnings were $-0.02 per share.
LCTX EPS surprise of 21.57%Analysts estimated LCTX earnings of $-0.01 per share this quarter (Q4). LCTX's actual earnings were $-0.01 per share.
LCTX EPS surprise of -14.94%Analysts estimated LCTX earnings of $-0.04 per share this quarter (Q3). LCTX's actual earnings were $-0.02 per share.
LCTX EPS surprise of 54.23%Analysts estimated LCTX earnings of $-0.05 per share this quarter (Q2). LCTX's actual earnings were $-0.03 per share.
LCTX EPS surprise of 36.03%Analysts estimated LCTX earnings of $-0.04 per share this quarter (Q4). LCTX's actual earnings were $-0.03 per share.
LCTX EPS surprise of -17.58%Analysts estimated LCTX earnings of $-0.04 per share this quarter (Q3). LCTX's actual earnings were $-0.04 per share.
LCTX EPS surprise of -8.47%